Titterton Lewis H jr's Form 4 filing
Anixa Biosciences Inc (ANIX) · filed Aug 1, 2024
- Accession no.
- 0001493152-24-029884
- Filed
- Aug 1, 2024
- Trade date
- Jul 30-31, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $84.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Titterton Lewis H jrCIK 0001499254 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | Common Stock | PPurchaseAcquired | +21,646 | $3.06 | +$66,236.76 | 890,754 | Direct | |
| Jul 31, 2024 | Common Stock | PPurchaseAcquired | +5,580 | $3.23 | +$18,023.4 | 896,334 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.